D-0487-2026 Class II Ongoing

Recalled by Island Kinetics, Inc. D.B.A. CoValence Laboratories — Chandler, AZ

FDA drug recall D-0487-2026 was initiated by Island Kinetics, Inc. D.B.A. CoValence Laboratories on Apr 1, 2026 and is designated Class II. Reason for recall: Failed Stability Specifications The recall status is ongoing. Affected quantity: 28,163 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 22, 2026
Initiation Date
Apr 1, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
28,163 bottles

Product description

Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.

Reason for recall

Failed Stability Specifications

Distribution pattern

U.S. Nationwide

Code information

Lot#: 4228D2, 4229D1, Exp.: 07/31/2026 Lot#: 5147D2, Exp.: 04/30/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0487-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0487-2026. Report a data issue: hello@regdatalab.com.